Request Deal Involvement

Leaps by Bayer led a $105m Series B round in Senti Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Red House Consulting

pr advisors

Red House Consulting

or

Principals

8VC (EIGHT PARTNERS LLC)

bidder

8VC (EIGHT PARTNERS LLC)

LUX CAPITAL MANAGEMENT

bidder

LUX CAPITAL MANAGEMENT

RIDGEBACK CAPITAL INVESTMENTS

bidder

RIDGEBACK CAPITAL INVESTMENTS

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

AMGEN INC

bidder

AMGEN INC

MATRIX PARTNERS

bidder

MATRIX PARTNERS

SENTI BIOSCIENCES

target

SENTI BIOSCIENCES

LEAPS BY BAYER

bidder

LEAPS BY BAYER

MIRAE ASSET FINANCIAL GROUP

bidder

MIRAE ASSET FINANCIAL GROUP

INTEL CAPITAL CORP

bidder

INTEL CAPITAL CORP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Leaps by Bayer led a $105m Series B round in Senti Bio.